Recent data consistently suggest that TUBB3 and TS expression were significantly correlated to poor outcomes in NSCLC patients; therefore, their expression could correlate to aggressive tumour behavior and increased proliferative activity [34, 35]. The gene discussed is TYMS; the disease is non-small cell lung carcinoma.